Phyllodes tumour of the breast: clinical follow-up of 33 cases of this rare disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: European Journal of Obstetrics & Gynecology, and Reproductive Biology, 138, 2, S. 217-221
- Event
-
Veröffentlichung
- (where)
-
Augsburg
- (who)
-
Universität Augsburg
- (when)
-
2008
- Event
-
Veröffentlichung
- (where)
-
Amsterdam
- (who)
-
Elsevier
- (when)
-
2008
- Creator
- DOI
-
10.1016/j.ejogrb.2007.08.002
- URN
-
urn:nbn:de:bvb:384-opus4-845189
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lenhard, M. S.
- Kahlert, S.
- Himsl, I.
- Ditsch, Nina
- Untch, M.
- Bauernfeind, I.
- Universität Augsburg
- Elsevier
Time of origin
- 2008
Other Objects (12)
Prognostische Relevanz disseminierter CK18-positiver-Zellen im Knochenmark nodal-negativer Mammakarzinom-Patientinnen und Nachweis des Östrogenrezeptors (ÖR) auf disseminierten CK18-positiven-Zellen im Knochenmark von Mammakarzinom-Patientinnen
Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: an ENIGMA resource to support clinical variant classification
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers
The significance of HPV in the follow-up period after treatment for CIN
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
Use of novel serum markers in clinical follow-up of Sertoli-Leydig cell tumours
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores
Atlas der Brustchirurgie : Operationstechniken Step by Step
Prognostische Relevanz disseminierter CK18-positiver-Zellen im Knochenmark nodal-negativer Mammakarzinom-Patientinnen und Nachweis des Östrogenrezeptors (ÖR) auf disseminierten CK18-positiven-Zellen im Knochenmark von Mammakarzinom-Patientinnen
Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: an ENIGMA resource to support clinical variant classification
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers
The significance of HPV in the follow-up period after treatment for CIN
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
Use of novel serum markers in clinical follow-up of Sertoli-Leydig cell tumours
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores
Atlas der Brustchirurgie : Operationstechniken Step by Step
Prognostische Relevanz disseminierter CK18-positiver-Zellen im Knochenmark nodal-negativer Mammakarzinom-Patientinnen und Nachweis des Östrogenrezeptors (ÖR) auf disseminierten CK18-positiven-Zellen im Knochenmark von Mammakarzinom-Patientinnen
Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: an ENIGMA resource to support clinical variant classification
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers
The significance of HPV in the follow-up period after treatment for CIN
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
Use of novel serum markers in clinical follow-up of Sertoli-Leydig cell tumours
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores